VRTX
436.98 USD
-2.23%
Today
+0.10%
1D
Market is closed
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 11:00 PM
Sat
Closed
Information
Name
Vertex Pharmaceuticals Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
109.85B
Avg Daily Volume
1.36M
52 Week High
510.77 USD
52 Week Low
362.5 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of SCD and TDT; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 clinical trial; inaxaplin for the treatment of APOL1-mediated kidney disease, which is in single Phase 2 trial; VX-264 for treating Type 1 Diabetes; VX-670 for the treatment of myotonic dystrophy type 1; and VX-407, a small molecule corrector for the treatment of autosomal dominant polycystic kidney disease. The company sells its products primarily to specialty pharmacy and distributors, wholesalers, retail pharmacies, hospitals, and clinics. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Top News
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
tradingview.com
4d ago
AbbVieInc
-1.94%
AirProd
+0.32%
AresManagement
-4.10%
Coeur
+2.59%
CFIndustries
+1.73%
California.Resources
+0.79%
CytomX.Therapeutics
+4.05%
DocuSign-Inc
-3.73%
Duolingo
-0.37%
Fair_Isaac
-13.78%
General_Mills
-3.29%
Hecla.Mining
+0.73%
IntuitiveS
-0.97%
Knight-Swift
+0.90%
Lucid
-2.17%
Lennar
+0.51%
Macys
-1.36%
MicroStrategy
-0.76%
MicronTech
-0.08%
Nebius.Group
+6.52%
NewmontM
+2.35%
NetflixInc
+0.96%
Ormat
+1.26%
Protagonist
-5.01%
Starbucks
-0.20%
SLGreen
+0.95%
SoFiTech
-0.12%
ConstellationBrands
+4.05%
T1.Energy
+12.29%
TradeDesk-Class-A
-2.34%
Vertex
+0.10%
WesternAlliance
-0.84%
Block
-0.38%
BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
reuters.com
3w ago
AbbVieInc
-1.94%
AirProd
+0.32%
AresManagement
-4.10%
Coeur
+2.59%
CFIndustries
+1.73%
California.Resources
+0.79%
CytomX.Therapeutics
+4.05%
DocuSign-Inc
-3.73%
Duolingo
-0.37%
Fair_Isaac
-13.78%
General_Mills
-3.29%
Hecla.Mining
+0.73%
IntuitiveS
-0.97%
Knight-Swift
+0.90%
Lucid
-2.17%
Lennar
+0.51%
Macys
-1.36%
MicroStrategy
-0.76%
MicronTech
-0.08%
Nebius.Group
+6.52%
NewmontM
+2.35%
NetflixInc
+0.96%
Ormat
+1.26%
Protagonist
-5.01%
Starbucks
-0.20%
SLGreen
+0.95%
ConstellationBrands
+4.05%
T1.Energy
+12.29%
TradeDesk-Class-A
-2.34%
Vertex
+0.10%
WesternAlliance
-0.84%
Block
-0.38%
BUZZ-U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies
reuters.com
3w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
